Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Plos One|December 24, 2010
Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolismVeronique Michaud, Martin Frappier, Marie-Christine Dumas, et al.Pharmacy (Basel, Switzerland)|December 1, 2020
Effectiveness of an Advanced Clinical Decision Support System on Clinical Decision-Making Skills in a Call Center Medication Therapy Management Pharmacy Setting: A Pilot StudyJennifer M Bingham, Veronique Michaud, Jacques Turgeon, et al.Pharmaceutics|September 29, 2017
Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic TissuesSarah Maximos, Michel Chamoun, Sophie Gravel, et al.International Journal of Molecular Sciences|July 5, 2019
A Pilot Study towards the Impact of Type 2 Diabetes on the Expression and Activities of Drug Metabolizing Enzymes and Transporters in Human DuodenumSophie Gravel, Benoit Panzini, Francois Belanger, et al.Critical Care Medicine|February 7, 2013
Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factorsYoanna Skrobik, Caroline Leger, Mariève Cossette, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 16, 2016
Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in humanAlexia Grangeon, Sophie Gravel, Fleur Gaudette, et al.Polymers|February 11, 2023
Colombian Sustainability Perspective on Fused Deposition Modeling Technology: Opportunity to Develop Recycled and Biobased 3D Printing FilamentsMaria A Morales, Alejandro Maranon, Camilo Hernandez, et al.Pharmacy (Basel, Switzerland)|November 21, 2023
The Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-AnalysisSavanna SanFilippo, Jacques Turgeon, Veronique Michaud, et al.Clinical Pharmacology and Therapeutics|May 18, 2019
Modulation of CYP450 Activities in Patients With Type 2 DiabetesSophie Gravel, Jean-Louis Chiasson, Jacques Turgeon, et al.Clinical Pharmacology and Therapeutics|April 20, 2019
Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 DiabetesSophie Gravel, Jean-Louis Chiasson, Fleur Gaudette, et al.Pageof 7